|
|
||||||||||
|
J Am Coll Cardiol, 2007; 50:2369-2374, doi:10.1016/j.jacc.2007.08.048
(Published online 11 December 2007). © 2007 by the American College of Cardiology Foundation |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Institute of Cardiology
Division of Anatomic Pathology and Histology
Institute of Medical Pathology
Institute of Hygiene, Catholic University of Sacred Heart, Rome, Italy
|| Neurobiology and Molecular Medicine Institute, National Council of Research, Rome, Italy
¶ Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy
Manuscript received April 16, 2007; revised manuscript received August 6, 2007, accepted August 13, 2007.
* Reprint requests and correspondence: Dr. Maria Lucia Narducci, Institute of Cardiology, Largo "A. Gemelli" n.8, 00168 Rome, Italy (Email: lianarducci{at}yahoo.it).
Objectives: We evaluated telomerase activity in circulating polymorphonuclear neutrophils (PMN) and in PMN isolated from coronary atherosclerotic plaques by a novel approach.
Background: Delayed apoptosis of PMN have been demonstrated in unstable angina (UA). These cells have a finite lifespan with low telomerase activity, a polymerase that extends telomeres, structures essential for cell aging. Reactivation of telomerase has been associated with resistance to apoptosis.
Methods: We studied 20 patients with UA and 6 patients with chronic stable angina (SA), undergoing a percutaneous coronary intervention. Circulating PMN were isolated from venous blood and PMN derived from coronary plaque were isolated from washing medium of angioplasty balloons.
Results: Telomerase activity was higher in coronary plaque PMN of UA patients than in coronary plaque PMN of SA patients (122.7, range 20.5 to 3,696; and 47.7, range 16 to 212.6, respectively, p = 0.001) and higher than in peripheral PMN of SA patients (122.7, range 20.5 to 3,696 vs. 59, range 16.5 to 132.5, p = 0.001). We found a statistically significant difference between venous and coronary plaque PMN telomerase activity in UA patients (z = –2.875; p = 0.004). Among UA patients, a shorter time interval from symptom onset to coronary PMN sampling was the only independent predictor of high telomerase activity in coronary plaque PMN (p < 0.001, R2 = 0.75).
Conclusions: In UA patients, telomerase activity is high in coronary plaque PMN, while it is low in peripheral PMN. Telomerase reactivation in resident PMN resulting in a prolonged lifespan might play a key role in the early phases of instability.
| ||||||||
This article has been cited by other articles:
![]() |
D. C. Sane Telomerase-positive neutrophils: plaque "survivors" and restenosis. J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2443 - 2444. [Full Text] [PDF] |
||||
![]() |
M. L. Narducci, A. Grasselli, L. M. Biasucci, A. Farsetti, A. Mule, G. Liuzzo, G. Niccoli, R. Mongiardo, A. Pontecorvi, and F. Crea Reply. J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2444 - 2444. [Full Text] [PDF] |
||||
![]() |
I. Spyridopoulos, Y. Erben, T. H. Brummendorf, J. Haendeler, K. Dietz, F. Seeger, C. K. Kissel, H. Martin, J. Hoffmann, B. Assmus, et al. Telomere Gap Between Granulocytes and Lymphocytes Is a Determinant for Hematopoetic Progenitor Cell Impairment in Patients With Previous Myocardial Infarction Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 968 - 974. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |